α-methylacyl-CoA-racemase expression in adenocarcinoma, dysplasia and non-neoplastic epithelium of the stomach

Oncology

Volumn 71, Issue 3-4, 2007, Pages 246-250

  Lee, Won Ae ^a  

^a Dankook University   (South Korea)

Author keywords

Methylacyl CoA racemase; AMACR; Dysplasia; Gastric carcinoma; Immunohistochemistry

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE;

ARTICLE; DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; STOMACH BIOPSY; STOMACH EPITHELIUM; STOMACH MUCOSA;

ADENOCARCINOMA; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROGNOSIS; RACEMASES AND EPIMERASES; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34548074708     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106428     Document Type: Article

References (24)

1. Ferdinandusse S, Denis S, Van Roermund CW, Wanders RJ, Dacremont G: Identification of the peroxisomal beta-oxidation enzymes involved in the degradation of long-chain dicarboxylic acids. J Lipid Res 2004;45:1104-1111.
2. Schmitz W, Albers C, Fingerhut R, Conzelmann E: Purification and characterization of an alpha-methylacyl-CoA racemase from human liver. Eur J Biochem 1995;231:815-822.
3. Farinola MA, Epstein JI: Utility of immunohistochemistry for alpha-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy. Hum Pathol 2004;35:1272-1278.
4. Jiang Z, Woda BA, Rock KL, Xu Y, Savas L, Khan A, Pihan G, Cai F, Babcook JS, Rathanaswami P, Reed SG, Xu J, Fanger GR: P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol 2001;25:1397-1404.
5. Hameed O, Sublett J, Humphrey PA: Immunohistochemical stains for p63 and alphamethylacyl-CoA racemase, versus a cocktail comprising both, in the diagnosis of prostatic carcinoma: a comparison of the immunohistochemical staining of 430 foci in radical prostatectomy and needle biopsy tissues. Am J Surg Pathol 2005;29:579-587.
6. Jiang Z, Woda BA, Wu CL, Yang XJ: Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S). Am J Clin Pathol 2004;122:275-289.
7. Varma M, Jasani B: Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature. Histopathology 2005;47:1-16.
8. Wu CL, Yang XJ, Tretiakova M, Patton KT, Halpern EF, Woda BA, Young RH, Jiang Z: Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia. Hum Pathol 2004;35:1008-1013.
9. Zhou M, Chinnaiyan AM, Kleer CG, Lucas PC, Rubin MA: Alpha-methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions. Am J Surg Pathol 2002;26:926-931.
10. Suh N, Yang XJ, Tretiakova MS, Humphrey PA, Wang HL: Value of CDX2, villin, and alpha-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Mod Pathol 2005;18:1217-1222.
11. Zhou M, Roma A, Magi-Galluzzi C: The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms. Clin Lab Med 2005;25:247-257.
12. Witkiewicz AK, Varambally S, Shen R, Mehra R, Sabel MS, Ghosh D, Chinnaiyan AM, Rubin MA, Kleer CG: Alpha-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis. Cancer Epidemiol Biomarkers Prev 2005;14:1418-1423.
13. Jiang Z, Fanger GR, Woda BA, Banner BF, Algate P, Dresser K, Xu J, Chu PG: Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: a study of 761 cases. Hum Pathol 2003;34:792-796.
14. Hornick JL, Lauwers GY, Odze RD: Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver. Am J Surg Pathol 2005;29:381-389.
15. Kuefer R, Varambally S, Zhou M, Lucas PC, Loeffler M, Wolter H, Mattfeldt T, Hautmann RE, Gschwend JE, Barrette TR, Dunn RL, Chinnaiyan AM, Rubin MA: α-Methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiation. Am J Pathol 2002;161:841-848.
16. Chen ZM, Ritter JH, Wang HL: Differential expression of alpha-methylacyl coenzyme A racemase in adenocarcinomas of the small and large intestines. Am J Surg Pathol 2005;29:890-896.
17. Langner C, Rupar G, Leibl S, Hutterer G, Chromecki T, Hoefler G, Rehak P, Zigeuner R: Alpha-methylacyl-CoA racemase (AMACR/P504S) protein expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression. Virchows Arch 2006;448:325-330.
18. Jiang Z, Fanger GR, Banner BF, Woda BA, Algate P, Dresser K, Xu J, Reed SG, Rock KL, Chu PG: A dietary enzyme: alpha-methylacyl-CoA racemase/P504S is overexpressed in colon carcinoma. Cancer Detect Prev 2003;27:422-426.
19. Rubin MA, Bismar TA, Andren O, Mucci L, Kim R, Shen R, Ghosh D, Wei JT, Chinnaiyan AM, Adami HO, Kantoff PW, Johansson JE: Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death. Cancer Epidemiol Biomarkers Prev 2005;14:1424-1432.
20. Lauwers GY, Shimizu M, Correa P, Riddell RH, Kato Y, Lewin KJ, Yamabe H, Sheahan DG, Lewin D, Sipponen P, Kubilis PS, Watanabe H: Evaluation of gastric biopsies for neoplasia: differences between Japanese and Western pathologists. Am J Surg Pathol 1999;23:511-518.
21. Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, Dixon MF, Fenoglio-Preiser CM, Flejou JF, Geboes K, Hattori T, Hirota T, Itabashi M, Iwafuchi M, Iwashita A, Kim YI, Kirchner T, Klimpfinger M, Koike M, Lauwers GY, Lewin KJ, Oberhuber G, Offner F, Price AB, Rubio CA, Shimizu M, Shimoda T, Sipponen P, Solcia E, Stolte M, Watanabe H, Yamabe H: The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-255.
22. Rugge M, Correa P, Dixon MF, Hattori T, Leandro G, Lewin K, Riddell RH, Sipponen P, Watanabe H: Gastric dysplasia: the Padova international classification. Am J Surg Pathol 2000;24:167-176.
23. Rugge M, Shiao YH, Correa P, Baffa R, DiMario F: Immunohistochemical evidence of p53 overexpression in gastric epithelial dysplasia. Cancer Epidemiol Biomarkers Prev 1992;1:551-554.
24. Aoi T, Marusawa H, Sato T, Chiba T, Maruyama M: Risk of subsequent development of gastric cancer in patients with previous gastric epithelial neoplasia. Gut 2006;55:588-589.